TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 34 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55 | -39.6% | 311 | 0.0% | 0.00% | – |
| Q2 2023 | $91 | -84.5% | 311 | 0.0% | 0.00% | – |
| Q1 2023 | $588 | +27.0% | 311 | 0.0% | 0.00% | – |
| Q4 2022 | $463 | -92.3% | 311 | -91.4% | 0.00% | – |
| Q3 2022 | $6,000 | -14.3% | 3,600 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | -22.2% | 3,600 | 0.0% | 0.00% | – |
| Q1 2022 | $9,000 | +80.0% | 3,600 | +350.0% | 0.00% | – |
| Q2 2021 | $5,000 | -44.4% | 800 | -27.3% | 0.00% | – |
| Q1 2021 | $9,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,764,508 | $848,082 | 0.28% |
| Ikarian Capital, LLC | 2,765,530 | $492,265 | 0.06% |
| JOHNSON & JOHNSON | 84,003 | $14,953 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 258,844 | $46,074 | 0.00% |
| BlackRock Inc. | 267,821 | $47,673 | 0.00% |
| Bank of New York Mellon Corp | 10,259 | $1,826 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 15,835 | $2,819 | 0.00% |
| Truvestments Capital LLC | 318 | $57 | 0.00% |
| Tower Research Capital LLC (TRC) | 10,407 | $1,852 | 0.00% |
| Cutler Group LLC / CA | 1,200 | $0 | 0.00% |